The Global Flow Cytometry Market to witness growing demand for Flow Cytometry which is primarily attributed to the rising research and development activities in the healthcare industry. Further, the rising prevalence of chronic and immunological ailments like HIV & AIDS and cancer due to gene mutations, such as smoking, radiation, viruses, cancer-causing chemicals (carcinogens), obesity, hormones, chronic inflammation, and a lack of exercise.
According to the latest report published by DelveInsight Flow Cytometry Market Insight, Competitive Landscape & Market Forecast 2027, the global Flow Cytometry Market is expected to witness appreciable growth in product demand owing to various reasons, one of the major factors influencing the growth of the Flow Cytometry Market is the fact that the diagnosis of HIV & AIDS and cancer is made by flow cytometry thereby increasing the demand of the device in the market. Additionally, rising advancements in stem cell research and recombinant DNA technology in the development of cancerous and immunology drugs and increasing advancements in flow cytometry software such as providing high-resolution imaging, fluorescence, and laser technology, and others across the world are anticipated to bolster the market, thereby contributing to the growth of the Flow Cytometry Market during the forecast period from 2022-2027.
Interested in knowing how the Flow Cytometry Market is expected to grow by 2027? Click to get a snapshot of the Flow Cytometry Market Sample Report
Flow Cytometry Overview
Flow Cytometry is a technology that provides rapid multi-parametric analysis of single cells in solution. Flow cytometers utilize lasers as light sources to produce scattered and fluorescent light signals that detectors such as photodiodes or photomultiplier tubes read. The instrument used in the analysis is known as a flow cytometer. The technology has applications in immunology, molecular biology, bacteriology, virology, cancer biology, and infectious disease monitoring.
Flow Cytometry Market Insight
Among all the regions, North America is expected to occupy the largest share in the global Flow Cytometry Market in the year 2021 and continue to do the same during the forecast period from 2022 to 2027. This domination is due to the increasing research and development activities, and the rising prevalence of chronic and infectious diseases like cancer and AIDS will increase the demand for flow cytometry in North America, leading to a rise in the overall Flow Cytometry Market growth in this region.
The flow cytometry technique is also used to detect tumor cell DNA aneuploidy, analyze tumor cell proliferation, and immunophenotyping leukemia. The increasing prevalence of cancer across the United States will increase the demand for flow cytometry techniques for diagnostic purposes. Thus, the increasing demand will propel the overall Flow Cytometry Market growth of the device in North America during the forecast period.
Moreover, the growing adoption of technologically advanced flow cytometry such as fluorescence and laser technology, high-resolution imaging, examination of intracellular compartments of the cells, and digitalization will further boost the demand for the device in North America, leading to a rise in the overall Flow Cytometry Market growth.
Recent Developments in the Flow Cytometry Market report:
- In April 2022, Sysmex Europe, a trusted provider of automated workflow solutions in the disciplines of hematology, urinalysis, and hemostasis, announced the launch of its Flow Cytometer XF-1600, which has received CE marking. XF-1600 offers clinical flow cytometry laboratories a robust, high-performance 10-colour analyzer for highly efficient and reliable data collection for immunophenotyping.
- In April 2022, BD, a leading global medical technology company, announced the launch of a new family of reagents, Horizon RealYellow 586 Reagents, that enables researchers to gain improved data resolution and greater insights from samples as compared to traditional fluorochromes. The launch of BD Horizon RealYellow 586 Reagents marks the first fluorochrome in a series from the new BD Horizon RealYellow and RealBlue Reagents product family. These reagents are a significant breakthrough in flow cytometry and can potentially accelerate discovery and drug development in many diseases.
- In February 2022, KCAS, a U.S.-based contract research organization (CRO) providing GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and cell/gene therapy industries, has acquired FlowMetric, LLC, a provider of flow cytometry and cellular assay R&D services to biotech, pharmaceutical, and cell/gene therapy industries.
- In August 2021, BD, a global medical technology company, announced the launch of a new benchtop cell analyzer- FACSymphony A1 Cell Analyzer that brings sophisticated flow cytometry capabilities to laboratories of all sizes. The analyzer is a fluorescence-activated cell analyzer that offers advanced research capabilities in a compact design, which helps improve access to instrumentation for complex scientific research in more labs.
- In June 2021, Thermo Fisher Scientific, one of the world leaders in serving science in scientific instrumentation, reagents and consumables, and software, announced that they had launched Invitrogen Attune CytPix Flow Cytometer and imaging-enhanced flow cytometer that combines acoustic focusing flow cytometry technology with a high-speed camera.
Want to better understand why North America is captivating the major Flow Cytometry Market share? Click to get a snapshot of Flow Cytometry Market Analysis
Key Players in the Flow Cytometry Market
Some of the leading Flow Cytometry Market players operating in the Flow Cytometry Market include Thermo Fisher Scientific Inc., BD, Stratedigm, Inc, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex Corporation, Agilent Technologies, Inc., Sony Biotechnology Inc., bioMérieux SA, Enzo Life Sciences, Inc., Union Biometrica, Inc., Cytek Biosciences, Sartorius AG, Beckman Coulter, Inc., Apogee Flow Systems Ltd., Molecular Instruments, Inc., Integrated DNA Technologies, Inc., New England Biolabs (NEB), ACROBiosystems, among others.
Flow Cytometry Market Dynamics
The Flow Cytometry Market is witnessing positive market growth owing to increasing research and development activities, rising prevalence of cancer and immunodeficiency disorders, rising advancements in stem cell research and recombinant DNA technology, increasing advancements in flow cytometry software across the world are anticipated to bolster the market. The diagnosis of HIV & AIDS and cancer is made by flow cytometry, thereby increasing the demand for the device in the Flow Cytometry Market. Additionally, rising advancements in stem cell research and recombinant DNA technology in the development of cancerous and immunology drugs and increasing advancements in flow cytometry software such as providing high-resolution imaging, fluorescence, and laser technology, and others across the world are anticipated to bolster the market, thereby contributing to the growth of the Flow Cytometry Market during the forecast period from 2022-2027. Moreover, technological advancements in flow cytometry will be a driving factor for the market. Advancements like live-cell imaging, super-resolution, fluorescence and laser technology, high-resolution imaging, examination of intracellular compartments of the cells, and digitalization will drive the Flow Cytometry Market during the forecast period. Hence, various applications and technological advancements in the area of flow cytometry will increase the market demand for the instrument leading to an overall rise in the Flow Cytometry Market growth during the forecast period.
However, on the other hand, the high cost of flow cytometers and dearth of skilled professionals in remote regions may hamper the Flow Cytometry Market growth. The ongoing COVID-19 pandemic has significantly impacted the Flow Cytometry Market as the research & developmental activities were halted for some time. During the initial phase of pandemic, the Flow Cytometry Market had witnessed little downfall due to stringent lockdown guidelines and social distancing norms. The supply of raw materials and other resources were also unavailable, due to which the key players in the market stopped their manufacturing units, ultimately leading to the decline in the stock of the device in the market. But, with the normalcy and with the return of resources, the market picked up the momentum again. The research & developmental industry demanded the device for the analysis of viral and chronic diseases. Owing to this fact, the leading market players accelerated their production of flow cytometers, thereby increasing the market demand of the flow cytometry, in turn, propelling the Flow Cytometry Market during the forecast period.
To better understand the short/long-term impact of COVID-19 on the Flow Cytometry Market. Get a snapshot @ Flow Cytometry Market Impact Due to COVID-19
Scope of the Flow Cytometry Market Report
- Coverage: Global
- Study Period: 2019-2027
- Market Segmentation By Product And Services Type: Instruments, Kits & Reagents, And Others
- Market Segmentation By Technology Type: Cell-Based Flow Cytometry And Bead-Based Flow Cytometry
- Market Segmentation By Application: Oncology, Drug Discovery, Stem Cell Therapy, , Hematology, Immunology, And Other Applications
- Market Segmentation By End-User: Academic & Research Institutes, Hospitals, Clinical Testing Laboratories, And Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Flow Cytometry Companies – Thermo Fisher Scientific Inc., BD, Stratedigm, Inc, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex Corporation, Agilent Technologies, Inc., Sony Biotechnology Inc., bioMérieux SA, Enzo Life Sciences, Inc., Union Biometrica, Inc., Cytek Biosciences, Sartorius AG, Beckman Coulter, Inc., Apogee Flow Systems Ltd., Molecular Instruments, Inc., Integrated DNA Technologies, Inc., New England Biolabs (NEB), ACROBiosystems, among others.
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Delveinsight Analysis: As per DelveInsight estimates, the Global Flow Cytometry Market was valued at USD 4.9 Billion in 2021, growing at a CAGR of 7.52% during the forecast period from 2022 to 2027 to reach USD 7.5 Billion by 2027.
Know more about which key player is set to dominate the Flow Cytometry Market @ Key Flow Cytometry Companies
Table of Contents
| 1 | Flow Cytometry Market Report Introduction |
| 2 | Flow Cytometry Market Executive Summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Flow Cytometry Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Flow Cytometry Market |
| 7 | Flow Cytometry Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Flow Cytometry Market Key Companies and Product Profiles |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Know more about Flow Cytometry @ Flow Cytometry Market Report Sample
Related Reports
Intranasal Drug Delivery Market
The Global Intranasal Drug Delivery Market report delivers an in-depth understanding and the historical and forecasted market trends, market drivers, market barriers, and key companies like AFT Pharmaceuticals, AptarGroup, Inc., SaNOtize Research & Development Corp., Becton, Dickinson and Company, Oyster Point Pharma, Inc., Impel Neuropharma, Teleflex Incorporated, SipNose, Kurve Technology, Inc, Mystic Pharmaceuticals, Medica Holdings, LLC, 3M Company, Neurelis, Inc., PENDOPHARM, GlaxoSmithKline. Cipla, Glenmark Pharmaceuticals, Novartis AG, AstraZeneca, Johnson & Johnson and others.
“DelveInsight’s ‘Drug-Eluting Stents – Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Drug-Eluting Stents and the historical and forecasted Drug-Eluting Stents market trends, market drivers, market barriers and key companies like Abbott, Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, STENTYS SA, Lepu Medical, Cook, Cardinal Health, and others.
Injectable Drug Delivery Devices Market
Global Injectable Drug Delivery Devices Market report delivers in-depth understanding and the historical and forecasted market trends, market drivers, market barriers and key companies like Eli Lilly and Company, Biocon, Becton, Dickinson & Company, West Pharmaceutical Services, Johnson & Johnson, Antares Pharma, AbbVie Inc, Pfizer Inc., Mylan N.V., Vetter Pharma-Fertigung GmbH & Co.KG, and others.
“DelveInsight’s ‘Novel Drug Delivery Devices – Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Novel Drug Delivery Devices and the historical and forecasted Novel Drug Delivery Devices market trends, market drivers, market barriers and key companies.
Transdermal Drug Delivery Devices Market
Transdermal Drug Delivery Devices Market report delivers in-depth understanding and the historical and forecasted market trends, market drivers, market barriers and key companies like Hisamitsu Pharmaceutical, Mylan, UCB SA, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Johnson & Johnson, Endo International, Purdue Pharma, Bristol-Myers Squibb Company, Endo Pharmaceuticals Inc., Acrux Limited, Lavipharm, Lead Chemicals Co. Inc., Luye Pharma Group, and others.
“DelveInsight’s ‘Surgical Microscopes Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Surgical Microscopes and the historical and forecasted Surgical Microscopes market trends, market drivers, market barriers, and key companies involved such as Novartis Ag, Danaher Corporation, Topcon Corporation, Carl Zeiss AG, Hagg-Streit Surgical GMBH, Accu-Scope Inc, Alltion (Wuzhou) Co., Ltd., Arri Medical, Karl Kaps GmbH & Co. Kg, Takagi Seiko Co. Ltd, and many others.
DelveInsight’s ‘Brain PET-MRI Systems Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Brain PET-MRI Systems and the historical and forecasted Brain PET-MRI Systems market trends, market drivers, market barriers and key companies involved such as Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Bruker, Mediso Ltd., MR Solutions, Cubresa Inc., Aspect Imaging, and many others.
DelveInsight’s ‘Computed Tomography Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Computed Tomography and the historical and forecasted Computed Tomography market trends, market drivers, market barriers and key companies involved such as GE Healthcare, Siemens Healthcare Private Limited, Toshiba Corporation, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Hitachi, Ltd, Shimadzu Corporation, PerkinElmer Inc, NeuroLogica Corp, and others.
DelveInsight’s ‘Ultrasound Devices Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Ultrasound Devices and the historical and forecasted Ultrasound Devices market trends, market drivers, market barriers and key companies involved such as FUKUDA DENSHI, Analogic Corporation, Hitachi, Ltd, Siemens Healthcare Private Limited, Toshiba Corporation, FUJIFILM Holdings Corporation, Canon Medical Systems Corporation, GE Healthcare, Sonacare Medical, and many others.
Transcatheter Heart Valve Replacement Devices Market
DelveInsight’s ‘Transcatheter Heart Valve Replacement Devices (THVR) Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of THVR and the historical and forecasted THVR market trends, market drivers, market barriers and key companies involved such as Edwards Lifesciences, Medtronic, Livanova plc, Abbott, Boston Scientific Corporation, CryoLife Inc, and others.
Congestive Heart Failure Treatment Devices Market
DelveInsight’s ‘Congestive Heart Failure Treatment Devices -Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of congestive heart failure treatment devices and the historical and forecasted congestive heart failure treatment devices market trends, market drivers, market barriers and key companies involved such as Abiomed, Medtronic, Abbott, Berlin Heart GmbH, Boston Scientific Corporation, HeartWare International, LivaNova PLC, and others.
DelveInsight’s ‘Deep Vein Thrombosis Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding and the historical and forecasted DVT market trends, market drivers, market barriers and key companies like Cardinal Health, BioTab Healthcare, Devon Medical Products, DJO LLC, Arjo, HealthyStep, Boston Scientific Corporation, Control Medical Technology, Cook Medical, medi, Zimmer Biomet, Encompass Group, LLC, and many others.
The Global Sinus Dilation Devices Market report delivers in-depth understanding and the historical and forecasted market trends, market drivers, market barriers and key companies like Johnson & Johnson, Stryker, Dalent Medical, Intersect ENT, Inc., Smith & Nephew, Medtronic, Meril Life Sciences Pvt. Ltd., Olympus, Jilin Coronado Medical Apparatus Co., Leno Medical Technology (Shanghai) Co., SPIGGLE & THEIS Medizintechnik GmbH, and others.
Global External Fixators Market report delivers in-depth understanding and the historical and forecasted market trends, market drivers, market barriers and key companies like Orthofix Medical Inc, Stryker Corporation, Smith & Nephew, Acumed Zimmer Biomet, Baumer S.A, Globus Medical, Orthosynthesis (Ortosintese), Mikai S.p.A, SOFEMED, and others.
Related Healthcare Trending Report
Staphylococcal Infections Market | Vertebral Body Replacement Systems Market | Opium Addiction Market | Exanthema Market | Lassa Fever Market | Ovarian Clear Cell Carcinoma Market | Female Infertility Market | Negative Pressure Wound Therapy (NPWT) Systems Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187